Emmaus Life Sciences, Inc.
EMMA
Price:
$0.0129
Market Cap:
$823.87K
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. Emmaus ...[Read more]
Industry
Biotechnology
IPO Date
2000-05-09
Stock Exchange
OTC
Ticker
EMMA
PE Ratio
[-0.11]
ROE
[12.66%]
Current Ratio
[0.07]
Dividend Yield
[0%]
Enterprise Value
[32.22M]
Dividend History
The PE Ratio as of December 2025 (TTM) for Emmaus Life Sciences, Inc. (EMMA) is -0.11
According to Emmaus Life Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.11. This represents a change of -4.82% compared to the average of -0.12 of the last 4 quarters.
Emmaus Life Sciences, Inc. (EMMA) Historical PE Ratio (quarterly & annually)
How has EMMA PE Ratio performed in the past?
The mean historical PE Ratio of Emmaus Life Sciences, Inc. over the last ten years is 2.51. The current -0.11 PE Ratio has changed -538.88% with respect to the historical average. Over the past ten years (40 quarters), EMMA's PE Ratio was at its highest in in the September 2023 quarter at 25.02. The PE Ratio was at its lowest in in the December 2020 quarter at -28.91.
Average
2.51
Median
-1.47
Minimum
-5.17
Maximum
44.42
Emmaus Life Sciences, Inc. (EMMA) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Emmaus Life Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 260.50%
Maximum Annual PE Ratio = 44.42
Minimum Annual Increase = -3026.15%
Minimum Annual PE Ratio = -5.17
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.08 | -94.15% |
| 2023 | -1.42 | 17.54% |
| 2022 | -1.21 | -76.52% |
| 2021 | -5.16 | -111.61% |
| 2020 | 44.42 | -3026.15% |
| 2019 | -1.52 | -70.63% |
| 2018 | -5.17 | 121.16% |
| 2017 | -2.34 | 260.50% |
| 2016 | -0.65 | -64.14% |
| 2015 | -1.81 | -78.46% |
Emmaus Life Sciences, Inc. (EMMA) Average PE Ratio
How has EMMA PE Ratio performed in the past?
The current PE Ratio of Emmaus Life Sciences, Inc. (EMMA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.91
5-year avg
7.31
10-year avg
2.51
Emmaus Life Sciences, Inc. (EMMA) PE Ratio vs. Peers
How is EMMA’s PE Ratio compared to its peers?
Emmaus Life Sciences, Inc.’s PE Ratio is less than SQZ Biotechnologies Company (-0.01), less than Orgenesis Inc. (163.72), less than Bio-Path Holdings, Inc. (-0.05), greater than Yulong Eco-Materials Limited (-8.40), greater than NeutriSci International Inc. (-1.08), less than Viropro Inc. (-0.00), less than Pure Harvest Corporate Group, Inc. (0.28), greater than Helix BioMedix, Inc. (-0.64), less than Vibe Growth Corporation (-0.06), less than Nutra Pharma Corp. (1.25),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.01 | $884.73K | |
| 163.72 | $3.88M | |
| -0.05 | $606.48K | |
| -8.40 | $585.26K | |
| -1.08 | $653.98K | |
| -0.00 | $25.40K | |
| 0.28 | $1.08M | |
| -0.64 | $626.93K | |
| -0.06 | $496.66K | |
| 1.25 | $3.55M |
Build a custom stock screener for Emmaus Life Sciences, Inc. (EMMA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Emmaus Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Emmaus Life Sciences, Inc. (EMMA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Emmaus Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Emmaus Life Sciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Emmaus Life Sciences, Inc. (EMMA)?
What is the highest PE Ratio for Emmaus Life Sciences, Inc. (EMMA)?
What is the 3-year average PE Ratio for Emmaus Life Sciences, Inc. (EMMA)?
What is the 5-year average PE Ratio for Emmaus Life Sciences, Inc. (EMMA)?
How does the current PE Ratio for Emmaus Life Sciences, Inc. (EMMA) compare to its historical average?